Table 2. Top 20 mRNAs significantly associated with the survival time of patients in the training set(n = 143).
| mRNA | HR | Cox p value | CI 95 |
|---|---|---|---|
| IGF2BP3 | 1.72 | 0 | 1.42–2.09 |
| CENPA | 2.18 | 1.00E-06 | 1.6–2.97 |
| CCNB2 | 2.2 | 1.00E-06 | 1.6–3.02 |
| KIF18A | 2.69 | 2.00E-06 | 1.78–4.06 |
| CLDN11 | 1.66 | 7.00E-06 | 1.33–2.08 |
| LOC101928583 | 1.66 | 7.00E-06 | 1.33–2.08 |
| TTK | 1.97 | 7.00E-06 | 1.47–2.65 |
| ZNF488 | 1.67 | 1.10E-05 | 1.33–2.09 |
| KIF20A | 1.92 | 1.20E-05 | 1.43–2.57 |
| DEPDC1 | 1.65 | 1.20E-05 | 1.32–2.06 |
| BUB1 | 1.93 | 1.20E-05 | 1.44–2.6 |
| PTTG1 | 2.26 | 1.30E-05 | 1.57–3.27 |
| ASPM | 1.65 | 1.50E-05 | 1.32–2.07 |
| NEK2 | 1.73 | 1.50E-05 | 1.35–2.21 |
| CEP55 | 1.8 | 1.70E-05 | 1.38–2.35 |
| TOP2A | 1.7 | 2.00E-05 | 1.33–2.16 |
| TPX2 | 1.94 | 2.20E-05 | 1.43–2.63 |
| NUF2 | 1.8 | 2.50E-05 | 1.37–2.36 |
| SOX11 | 1.56 | 2.60E-05 | 1.27–1.91 |
| DLGAP5 | 1.76 | 2.80E-05 | 1.35–2.29 |